| Laboratory: | Genomics (MOLECULAR DIAGNOSTICS) |
| Test Name: |
Heme-Onc NGS Sequence/fusion panel for myeloid neoplasms - (BM) (B)
Test Code:
HMD
|
| Clinical Information: |
Test Indications: Evaluation of hematologic neoplasms of myeloid origin at the time of diagnosis or possibly disease relapse, to help determine the diagnosis and/ or provide prognostic or therapeutic information for optimal clinical management. This is an out-of-center test, processed by the Shared Health Genomics laboratory. Testing is restricted to clinical hematologists
For proper routing and reporting of this test, the following two requisitions must be completed: 1. Molecular Hematopathology Test Requisition (R250-10-29) and 2. London Health Sciences Centre Molecular Genetics Requisition |
| Collection Devices: |
Preferred Device:
|
| Specimen Required: |
Blood: 2.0 mL
Adult: Bone Marrow Volume: 2.0 mL |
| Referral: |
Do NOT centrifuge. Store and ship specimens at room temperature. Specimens are not to be used for other tests (i.e. CBC). Samples requiring DNA and RNA extraction must be less than 3 days old on arrival to the referral lab or they will be deemed inadequate.
|
| Requisition: | |
| Reference Values: |
A descriptive report will be sent.
|
| Availability: |
Weekdays (Mon to Wed)
No collections on Thursday and Fridays due to sample shipping and receiving restrictions
|
| See Also: | |
| More Information: |